Jack E. Fincham

2.9k total citations
87 papers, 1.3k citations indexed

About

Jack E. Fincham is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Jack E. Fincham has authored 87 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Geriatrics and Gerontology, 22 papers in Economics and Econometrics and 18 papers in General Health Professions. Recurrent topics in Jack E. Fincham's work include Pharmaceutical Practices and Patient Outcomes (22 papers), Pharmaceutical Economics and Policy (12 papers) and Pharmacovigilance and Adverse Drug Reactions (11 papers). Jack E. Fincham is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (22 papers), Pharmaceutical Economics and Policy (12 papers) and Pharmacovigilance and Adverse Drug Reactions (11 papers). Jack E. Fincham collaborates with scholars based in United States, Netherlands and China. Jack E. Fincham's co-authors include Arif Ahmed, Jaxk Reeves, Albert I. Wertheimer, Mickey C. Smith, Matthew Perri, Alex Z. Fu, Gordon G. Liu, James H. Barnes, Abigail Alvarado-Vázquez and E. Alfonso Romero‐Sandoval and has published in prestigious journals such as Social Science & Medicine, Medical Care and The Journal of Clinical Psychiatry.

In The Last Decade

Jack E. Fincham

76 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack E. Fincham United States 18 338 276 227 190 169 87 1.3k
L. Douglas Ried United States 25 433 1.3× 464 1.7× 310 1.4× 296 1.6× 177 1.0× 100 1.9k
Stephanie Y. Crawford United States 21 260 0.8× 198 0.7× 140 0.6× 159 0.8× 127 0.8× 76 1.1k
Mitchell J. Barnett United States 27 324 1.0× 366 1.3× 274 1.2× 385 2.0× 95 0.6× 58 2.2k
David Newby Australia 20 199 0.6× 240 0.9× 150 0.7× 217 1.1× 83 0.5× 55 1.5k
Bruce A. Berger United States 19 445 1.3× 326 1.2× 111 0.5× 226 1.2× 297 1.8× 65 1.5k
Aline Hajj Lebanon 21 235 0.7× 230 0.8× 118 0.5× 329 1.7× 83 0.5× 95 1.8k
Kelly Grindrod Canada 22 459 1.4× 847 3.1× 166 0.7× 294 1.5× 194 1.1× 112 1.9k
Lynne Emmerton Australia 26 730 2.2× 1.1k 4.1× 250 1.1× 287 1.5× 242 1.4× 145 2.8k
David Scott United States 18 421 1.2× 368 1.3× 107 0.5× 217 1.1× 111 0.7× 83 1.2k
Karen Suchanek Hudmon United States 34 276 0.8× 833 3.0× 123 0.5× 758 4.0× 124 0.7× 144 3.2k

Countries citing papers authored by Jack E. Fincham

Since Specialization
Citations

This map shows the geographic impact of Jack E. Fincham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack E. Fincham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack E. Fincham more than expected).

Fields of papers citing papers by Jack E. Fincham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack E. Fincham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack E. Fincham. The network helps show where Jack E. Fincham may publish in the future.

Co-authorship network of co-authors of Jack E. Fincham

This figure shows the co-authorship network connecting the top 25 collaborators of Jack E. Fincham. A scholar is included among the top collaborators of Jack E. Fincham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack E. Fincham. Jack E. Fincham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yifei, et al.. (2025). Consumers’ expected information search behavior for a pharmaceutical treatment. Frontiers in Pharmacology. 16. 1466352–1466352.
2.
Fincham, Jack E. & Arif Ahmed. (2012). Dramatic Need for Cooperation and Advocacy Within the Academy and Beyond. American Journal of Pharmaceutical Education. 76(1). 1–1. 87 indexed citations
3.
Stoner, Steven C. & Jack E. Fincham. (2012). Faculty Role in Classroom Engagement and Attendance. American Journal of Pharmaceutical Education. 76(5). 75–75. 24 indexed citations
4.
Cantrell, C. Ron, Julie Priest, Christopher L. Cook, Jack E. Fincham, & Steven Burch. (2010). Adherence to Treatment Guidelines and Therapeutic Regimens: A US Claims-Based Benchmark of a Commercial Population. Population Health Management. 14(1). 33–41. 13 indexed citations
5.
Priest, Julie, C. Ron Cantrell, Jack E. Fincham, Christopher L. Cook, & Steven Burch. (2010). Quality of Care Associated with Common Chronic Diseases in a 9-State Medicaid Population Utilizing Claims Data: An Evaluation of Medication and Health Care Use and Costs. Population Health Management. 14(1). 43–54. 29 indexed citations
6.
Fincham, Jack E.. (2010). Financial Realities Affect Political Support for Health Care Reform. American Journal of Pharmaceutical Education. 74(1). 1–1. 175 indexed citations
7.
Ahmed, Arif & Jack E. Fincham. (2010). Physician Office vs Retail Clinic: Patient Preferences in Care Seeking for Minor Illnesses. The Annals of Family Medicine. 8(2). 117–123. 35 indexed citations
8.
Fincham, Jack E.. (2009). Leaders or Managers for Difficult Times. American Journal of Pharmaceutical Education. 73(2). 29–29. 2 indexed citations
9.
Brazeau, Gayle A., Joseph T. DiPiro, Jack E. Fincham, Bradley A. Boucher, & Timothy S. Tracy. (2008). Your Role and Responsibilities in the Manuscript Peer Review Process. American Journal of Pharmaceutical Education. 72(3). 69–69. 15 indexed citations
10.
Fincham, Jack E.. (2008). An Unfortunate and Avoidable Component of American Pharmacy: Tobacco. American Journal of Pharmaceutical Education. 72(3). 57–57. 2 indexed citations
11.
Fincham, Jack E.. (2008). An Unfortunate and Avoidable Component of American Pharmacy: Tobacco. American Journal of Pharmaceutical Education. 72(3). 57–57. 14 indexed citations
12.
Fincham, Jack E.. (2007). Public Health, Pharmacy, and the Prevention Education Resource Center (PERC). American Journal of Pharmaceutical Education. 71(5). 104–104. 7 indexed citations
13.
Fu, Alex Z., et al.. (2007). Potentially Inappropriate Medication Use and Healthcare Expenditures in the US Community-Dwelling Elderly. Medical Care. 45(5). 472–476. 133 indexed citations
14.
Fincham, Jack E., Miles B. Markus, Bongani M. Mayosi, et al.. (2005). Synchronized and regular deworming of children and women in South Africa : Policy and practice. South African Journal of Science. 101. 13–17. 3 indexed citations
15.
Howard, Patricia, et al.. (2002). Patterns of ACE Inhibitor Use in Elderly Medicaid Patients With Heart Failure. The American Journal of Geriatric Cardiology. 11(5). 287–294. 15 indexed citations
16.
Fincham, Jack E.. (1992). Perioperative implications of tobacco use. AORN Journal. 56(3). 531–532. 3 indexed citations
17.
Fincham, Jack E.. (1989). ADVERSE DRUG REACTION REPORTING AND PHARMACISTS. Journal of Clinical Pharmacy and Therapeutics. 14(2). 79–81. 10 indexed citations
18.
Carroll, Norman V., Jack E. Fincham, & Fred M. Cox. (1987). The Effects of Differences in State Drug Product Selection Laws on Pharmacists?? Substitution Behavior. Medical Care. 25(11). 1069–1077. 9 indexed citations
19.
Fincham, Jack E.. (1986). How Pharmacists are Rated as a Source of Drug Information by Physician Assistants. Drug Intelligence & Clinical Pharmacy. 20(5). 379–383. 4 indexed citations
20.
Fincham, Jack E.. (1985). The use of specialized patient medication information sheets with end stage renal disease patients: A pilot study. Patient Education and Counseling. 7(1). 43–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Douglas Ried Breakdown of academic impact, for papers by Stephanie Y. Crawford Breakdown of academic impact, for papers by Mitchell J. Barnett Breakdown of academic impact, for papers by David Newby Breakdown of academic impact, for papers by Bruce A. Berger Breakdown of academic impact, for papers by Aline Hajj Breakdown of academic impact, for papers by Kelly Grindrod Breakdown of academic impact, for papers by Lynne Emmerton Breakdown of academic impact, for papers by David Scott Breakdown of academic impact, for papers by Karen Suchanek Hudmon
Rankless by CCL
2026